MannKind (MNKD)
(Delayed Data from NSDQ)
$4.65 USD
-0.09 (-1.80%)
Updated Jun 6, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 181 - 200 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Transfer of Coverage: Maintaining a Market Perform Rating
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
A study of Afrezza with type 1 diabetics must show that two delivery devices are equivalent.
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
FDA Green Lights Type 1 and Type 2 Diabetes Pivotal Trial Designs.
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
FDA Green Lights Mannkind?s Type 1 and Type 2 Diabetes Pivotal Trial Designs.
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Reports Q211 results and provides an update on discussions with the FDA.
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Reports Q211 results and provides an update on discussions with the FDA.
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Transfer of coverage: Maintaining Market Perform rating.
Provider: RODMAN & RENSHAW, CO.
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Will set Afrezza?s clinical development path within a few weeks.
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
We are placing MannKind Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
We are placing MannKind Under Review due to the departure from the firm of analyst, Simos Simeonidis
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.